Cargando…

Administration of Once-daily Canagliflozin to a Non-diabetic Patient in Addition to Standard Aerobic Exercise: A Case Report

There is no Indian data at present on sodium-glucose cotransporter 2 (SGLT2) inhibitors' role on glycated haemoglobin A1c (HbA1c), weight, and blood pressure in non-diabetic individuals. This novel mechanism of action could assure us of sustained non-glycaemic benefits along with information on...

Descripción completa

Detalles Bibliográficos
Autor principal:	Roy, Sayak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550511/ https://www.ncbi.nlm.nih.gov/pubmed/31192057 http://dx.doi.org/10.7759/cureus.4352

Ejemplares similares

A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy
por: Roy, Sayak, et al.
Publicado: (2019)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

A Cross-sectional Retrospective Analysis of Glycemic Burden and Nephropathy in an Indian Population and Formulation of a New Plan Using eGFR/HbA1c Grid Formation
por: Roy, Sayak, et al.
Publicado: (2019)

Canagliflozin Prevents Hyperglycemia-Associated Muscle Extracellular Matrix Accumulation and Improves the Adaptive Response to Aerobic Exercise
por: MacDonald, Tara L., et al.
Publicado: (2022)

The Effect of Traditional Aerobic Exercise and Sprint Interval Training on Insulin Resistance in Men With Prediabetes: A Randomised Controlled Trial
por: Badaam, Khaled M, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient
por: Fugere, Tyler, et al.
Publicado: (2021)

The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus
por: Qasim, Muhammad, et al.
Publicado: (2022)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
por: Mubashir, Muaz, et al.
Publicado: (2022)

Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes
por: Yamagishi, Hirofumi, et al.
Publicado: (2023)

Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021
por: Shigeta, Haruki, et al.
Publicado: (2023)

THU281 Real-World Survey Of Adherence To Guidelines Regarding Type 1 Diabetes And Aerobic Exercise
por: Anthony Henske, Joseph, et al.
Publicado: (2023)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

Acute Psychosis Following Corticosteroid Administration
por: Kazi, Sana Elham, et al.
Publicado: (2021)

SAT042 Impact Of Aerobic Exercise On The Circulating Endothelial Progenitor Cells And Inflammation Markers In Type 1 Diabetes
por: Maraschin, Clara Krummenauer, et al.
Publicado: (2023)

Comparison of Incidence of Urinary Tract Infection in Diabetic vs Non-Diabetic and Associated Pathogens
por: Ramrakhia, Sonam, et al.
Publicado: (2020)

Clinical and Microbiological Profile of Urinary Tract Infections in Diabetic versus Non-Diabetic Individuals
por: Kumar, Ravi, et al.
Publicado: (2019)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

Assessment of Additional Risk Factors for Cardiovascular Disease and Awareness Among Adult Patients With Diabetes Mellitus: A Cross-Sectional Study From Northern Sri Lanka
por: Manoharan, Printhiny, et al.
Publicado: (2022)

SUN-183 Prolonged Glycosuria after Canagliflozin Discontinuation in a Patient with Euglycemic Diabetic Ketoacidosis
por: Dai, Yufei, et al.
Publicado: (2019)

SUN-169 A Case of Candidemia in a Patient with Diabetes on Canagliflozin Following Urologic Procedure
por: Raj, Rishi, et al.
Publicado: (2019)

Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
por: Ritze, Yvonne, et al.
Publicado: (2018)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths
por: Al Hayek, Ayman A, et al.
Publicado: (2020)

The Association Between Diabetes Mellitus and Osteoarthritis: Does Diabetes Mellitus Play a Role in the Severity of Pain in Osteoarthritis?
por: Chowdhury, Tutul, et al.
Publicado: (2022)

Effect of Non-Surgical Periodontal Therapy on Systemic Inflammatory Markers, Glycemic Status and Levels of Proteinuria in Type 2 Diabetic and Non-Diabetic Patients With Chronic Periodontitis
por: Sundaram, S Gopalakrishnan, et al.
Publicado: (2023)

A Case of Pseudogout Following Zoledronic Acid Administration
por: Hill, Alexander C, et al.
Publicado: (2021)

Glycemic Control and the Weight Benefit of a Daily 7 mg Dose of Oral Semaglutide Versus an Alternate-Day 14 mg Dose of Oral Semaglutide From an Ambulatory Glucose Monitoring Data: A Retrospective Cohort Study From Eastern India
por: RoyChaudhuri, Soumyabrata, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
por: Padda, Jaskamal, et al.
Publicado: (2021)

Hypoglycemia in a Non-diabetic Patient and the Side Effects of Diazoxide Use
por: Brito, Patrícia C, et al.
Publicado: (2023)

25(OH)D Serum Level in Non-Diabetic and Type II Diabetic Patients: A Cross-Sectional Study
por: AlHewishel, Mohmmed A, et al.
Publicado: (2020)

Factors for Social Stressors Among Type 2 Diabetics Versus Non-Diabetics Using the Hamilton Depression Rating Scale
por: Raja, Saadia Y, et al.
Publicado: (2020)

Assessment of Type 2 Diabetes Awareness and Knowledge in the Non-medical Bahraini Population
por: Khalaf, Saeed H, et al.
Publicado: (2023)

The Pathophysiology of Type 2 Diabetes Mellitus in Non-obese Individuals: An Overview of the Current Understanding
por: Olaogun, Idowu, et al.
Publicado: (2020)

Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II
por: Khludenev, George, et al.
Publicado: (2023)

Feto-Maternal Outcomes and Treatment Compliance in Metformin Versus Insulin-Treated Gestational Diabetic and Non-Diabetic Patients at the Rehman Medical Institute, Peshawar
por: Anthony, Nouman, et al.
Publicado: (2021)

A Thyrotoxicosis Surprise: Jod-Basedow Phenomenon Following IV Contrast Administration
por: Pokhrel, Akriti, et al.
Publicado: (2022)

Luseogliflozin Additively Enhances the Glucose-Lowering Effect of an Incretin Modulator in a High-Carbohydrate Diet
por: Lee, Gendai
Publicado: (2022)

A Retrospective Observational Study of Insulin Glargine in Type 2 Diabetic Patients with Advanced Chronic Kidney Disease
por: Majumder, Anirban, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hr711l5g2v1fpavh1vfocvv7g